Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly

ClinicalTrials.gov ID: NCT01995734

Public ClinicalTrials.gov record NCT01995734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An ACromegaly, Open-label, Multi-CEnter, Safety Monitoring Program for Treating Patients With SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The present study is planned as an expanded treatment protocol to provide acromegalic patients for whom medical therapy is appropriate access to pasireotide LAR while regulatory approval for pasireotide is sought.

Study identification

NCT ID
NCT01995734
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Dec 29, 2015

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Univ. of Alabama Birmingham Birmingham Alabama 35294 —
Advanced Research, LLC Advanced Reserch (4) Peoria Arizona 85381 —
St. Joseph's Hospital Medical Center St. Joseph's Hosp Med Ctr (2) Phoenix Arizona 85013 —
San Diego Coastal Endocrinology Group Chula Vista California 91911 —
University of Southern California Keck School of Medicine Los Angeles California 90033 —
University of California at Los Angeles UCLA - Los Angeles Los Angeles California 90095 —
John Wayne Cancer Institute Saint John's Health Center Santa Monica California 90404 —
Harbor-UCLA Medical Center Center for Men's Health Torrance California 90509 —
George Washington University Medical Center Medical Faculty Associates Inc Washington D.C. District of Columbia 20037 —
Center for Diabetes & Endocrine Care Dept.of Ctr for Diab&Endoc - 2 Hollywood Florida 33021 —
Central Florida Endocrine & Diabetes Consultants Maitland Florida 32751 —
Endocrine Assoc of FL Ocoee Florida 34761 —
Emory University School of Medicine/Winship Cancer Institute Emory University (5) Atlanta Georgia 30322 —
Dr. Steven Leichter, Endocrine Consultant Columbus Georgia 31901 —
Northwestern University Endo, Metabolism and Molecular Chicago Illinois 60611-3308 —
The Johns Hopkins University School of Medicine Johns Hopkins University Baltimore Maryland 21205 —
Sinai Hospital of Baltimore Sinai Hospital, Baltimore Baltimore Maryland 21215 —
Tufts Medical Center Tufts Medical Ctr Boston Massachusetts 02111 —
Mayo Clinic - Rochester Mayo Clinic (2) Rochester Minnesota 55905 —
Washington University St Louis Missouri 63110 —
PALM MEDICAL RESEARCH CENTER Palm Research Center, Inc Las Vegas Nevada 89148 —
Robert Wood Johnson Medical School Div. Endo, Meta & Nutrition New Brunswick New Jersey 08903 —
University of New Mexico School of Medicine Univ of NM Albuquerque New Mexico 87131 —
Stony Brook Internists PC East Setauket New York 11733 —
Mount Sinai School of Medicine Mt. Sinai Schoof of Med. New York New York 10029 —
Columbia University Medical Center- New York Presbyterian Neuroendocrine Unit New York New York 10032 —
Endocrine Associates of Long Island, P.C. Smithtown New York 11787 —
Endocrinology Associates Inc Columbus Ohio Columbus —
Toledo Clinic Toledo Clinic, Inc. Toledo Ohio 43623 —
Oregon Health & Sciences University Oregon Health & Sciences Portland Oregon 97239 —
Thomas Jefferson University Jefferson University Physician Philadelphia Pennsylvania 19107 —
Allegheny Endocrinology Associates Allegheny Endo Associates Pittsburgh Pennsylvania 15212 —
MidState Endocrine Associates Nashville Tennessee 37203 —
Vanderbilt University Medical Center Clinical Trials Center Nashville Tennessee 37212-3139 —
Baylor College of Medicine Division of Endocrinology Houston Texas 77030 —
Virginia Endocrinology Research Chesapeake Virginia 23321 —
Swedish Cancer Institute Swedish Neuroscience Institute Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01995734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01995734 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →